๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Thrombotic Microangiopathies

BCMA-CD19 CAR-T Therapy for Refractory Autoimmune Diseases NCT06794008Phase 21 site๐Ÿ“ Beijing Peking University People's Hospital ยท Tests: BCMA-CD19 CAR-T therapy Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford NCT01793168n/a1 site๐Ÿ“ Sioux Falls Sanford Health The Efficacy and Safety of Combined Teriflunomide and High-dose Dexamethasone in Newly Diagnosed Primary Immune Thrombocytopenia (TEMPO-2) NCT07065968Phase 23 sites๐Ÿ“ Beijing๐Ÿ“ Beijing๐Ÿ“ Beijing Peking University People's Hospital ยท Tests: Teriflunomide, Dexamethasone Turkey Thrombotic Thrombocytopenic Purpura Disease Registry: National Multicenter Study NCT05950750n/a1 site๐Ÿ“ Ankara Turkish Hematology Association Prospective Evaluation of Diagnosis and Treatment of Patients With Autoimmune Cytopenias Including Autoimmune Hemolytic Anemia, Immune Thrombocytopenia, and Chronic Idiopathic/Autoimmune Neutropenia NCT05931718n/a1 site๐Ÿ“ Milan Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico ยท Tests: cytokine essays, NGS, Fecal microbiome, Erythropoietin, Luspatercept A Study Investigating Intravenous Human Normal Immunoglobulin 10% in Adults With Chronic Immune Thrombocytopenia (ITP) NCT07059000Phase 328 sites๐Ÿ“ Los Angeles๐Ÿ“ Shirley๐Ÿ“ Greenville Kedrion S.p.A. ยท Tests: Kedrion IVIG 10% Exploring the Efficacy, Safety of a Modified Starting Dosage of Avatrombopag in Immune Throbocytopenia (ITP) - a Pilot Study NCT07133659Phase 41 site๐Ÿ“ Baghdad Al-Mustansiriyah University ยท Tests: Avatrombopag 20 mg Oral Tablet Study to Assess the Safety and Tolerability of Tafasitamab in Adult Participants With Primary Autoimmune Blood Cell Disorders NCT07104565Phase 239 sites๐Ÿ“ Glendale๐Ÿ“ Los Angeles๐Ÿ“ Lone Tree Incyte Corporation ยท Tests: INCA000585 Anti-CD38 Antibody Treating Pediatric Primary Immune Thrombocytopenia (ITP) NCT06168851Phase 21 site๐Ÿ“ Tianjin Institute of Hematology & Blood Diseases Hospital, China ยท Tests: Anti-CD38 antibody Injection Safety Study of CC312 in Autoimmune Disease Patients NCT06888960EARLY Phase 11 site๐Ÿ“ Tianjin CytoCares Inc ยท Tests: CC312 Immunological Aspect of Thrombotic Thrombocytopenic Purpura (TTP) NCT06945861n/a1 site๐Ÿ“ Rouen University Hospital, Rouen Anti-CD38 Antibody Treating Elderly Patients With Primary Immune Thrombocytopenia (ITP) NCT07063199Phase 21 site๐Ÿ“ Tianjin Institute of Hematology & Blood Diseases Hospital, China ยท Tests: Daratumumab Injection Post-Marketing Clinical Study of Ravulizumab in Participants With Clinical aHUS NCT07308574Phase 412 sites๐Ÿ“ Bunkyล City๐Ÿ“ Hirakata-shi๐Ÿ“ Iruma-Gun Alexion Pharmaceuticals, Inc. ยท Tests: Ravulizumab Evaluate Long-term Safety, Tolerability and Efficacy of Iptacopan in Study Participants With aHUS NCT05795140Phase 39 sites๐Ÿ“ Sรฃo Paulo๐Ÿ“ Rio de Janeiro๐Ÿ“ Beijing Novartis Pharmaceuticals ยท Tests: Iptcaopan 200 mg A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia NCT06948318Phase 3118 sites๐Ÿ“ Hot Springs๐Ÿ“ Los Angeles๐Ÿ“ San Diego Takeda ยท Tests: Mezagitamab Cognitive Dysfunction in Chronic and Persistent Immune Thrombocytopenia NCT06817395n/a1 site๐Ÿ“ Boston Massachusetts General Hospital A Prospective, One-arm and Open Clinical Study of Obinutuzumab in the Treatment of Pediatric Primary Immune Thrombocytopenia (ITP) NCT06094881Phase 21 site๐Ÿ“ Tianjin Institute of Hematology & Blood Diseases Hospital, China ยท Tests: Obinutuzumab Injection [Gazyva] High-Dose Dexamethasone Combined With Orelabrutinib Versus High-Dose Dexamethasone Combined With Placebo in Adult Patients With Newly Diagnosed Primary Immune Thrombocytopenia NCT07559331Phase 31 site๐Ÿ“ Jinan Shandong University ยท Tests: High-Dose Dexamethasone Combined with Orelabrutinib, High-Dose Dexamethasone Combined with Placebo Multi-target Drugs Sequential Combination Therapy in Adults Patients With Newly Diagnosed Primary Immune Thrombocytopenia NCT07788456Phase 41 site๐Ÿ“ Tianjin Institute of Hematology & Blood Diseases Hospital, China ยท Tests: standard-dose methylprednisolone/prednisone., thrombopoietin receptor agonist(TPO-RA), including but not limited to hetโ€ฆ V-IMMUNEยฎ for Immune Thrombocytopenia NCT06962631Phase 32 sites๐Ÿ“ Recife๐Ÿ“ Sรฃo Paulo On Pharma Importadora, Exportadora e Distribuidora de Medicโ€ฆ ยท Tests: 5% (5g/100 ml) intravenous immunoglobin Safety and Efficacy of Eculizumab in High-risk TA-TMA NCT07707687Phase 28 sites๐Ÿ“ Changsha๐Ÿ“ Hangzhou๐Ÿ“ Hangzhou First Affiliated Hospital of Zhejiang University ยท Tests: Eculizumab Sirolimus in Patients With Systemic Lupus Erythematosus-Associated Immune Thrombocytopenia NCT07657793Phase 2, Phase 31 site๐Ÿ“ Beijing Chinese SLE Treatment And Research Group ยท Tests: Sirolimus, Placebo Eltrombopag Induced Liver Dysfunction During Treatment of Immunethrombocytopenic Purpura NCT07093606NA1 site๐Ÿ“ Sohag Sohag University ยท Tests: Eltrombopag An Exploratory Study of CD19/CD22/BCMA CAR-T Cells (BZE2204) in Subjects With Relapsed or Refractory Autoimmune Diseases NCT07174843EARLY Phase 11 site๐Ÿ“ Shanghai Shanghai Cell Therapy Group Co.,Ltd ยท Tests: CD19/CD22/BCMA CAR-T cells(BZE2204) A Study in Children and, Adults With Congenital Thrombotic Thrombocytopenic Purpura (cTTP) Treated With Adzynma NCT07353099n/a7 sites๐Ÿ“ Vienna๐Ÿ“ Bonn๐Ÿ“ Cologne Takeda ยท Tests: No Intervention Observatory of Immunological Thrombopenic Purpura in the Brest Region NCT06556888n/a1 site๐Ÿ“ Brest University Hospital, Brest Safety and Preliminary Efficacy of CTX112 in Adult Participants With Relapsed/Refractory Hematologic Autoimmune Disease NCT07549698Phase 1, Phase 212 sites๐Ÿ“ Boston๐Ÿ“ Rochester๐Ÿ“ Omaha CRISPR Therapeutics AG ยท Tests: CTX112 Daratumumab Versus Rituximab in the Management of Pediatric Primary Immune Thrombocytopenia (ITP) NCT07362238Phase 21 site๐Ÿ“ Tianjin Institute of Hematology & Blood Diseases Hospital, China ยท Tests: Rituximab, Daratumumab Biological Bank for the Patients Followed in a Constitutive Reference Center for Autoimmune Cytopenia NCT04005638n/a1 site๐Ÿ“ Pessac University Hospital, Bordeaux ยท Tests: blood sample, urine sample The Investigate Efficacy and Safety Evaluation of Bortezomib in Patients With Relapsed/Refractory Immune Thrombocytopenia NCT05599880Phase 24 sites๐Ÿ“ Guri-si๐Ÿ“ Seoul๐Ÿ“ Seoul Seoul National University Hospital ยท Tests: Bortezomib
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy